Genetic Diseases

Top Story

CAMP4, Alnylam partner to identify rare liver disease genetic targets

January 24, 2019
Meeting News

Healio to provide live coverage of The Liver Meeting 2017

October 21, 2017
WASHINGTON — Beginning Friday, October 20, Healio Gastroenterology and Liver Disease will provide live coverage from the The Liver Meeting 2017. Held from Oct. 20…
Meeting News

Kanuma improves liver markers in patients with lysosomal acid lipase deficiency

December 6, 2016
BOSTON — Kanuma improved various liver markers, as well as reduced liver fibrosis and cirrhosis, in children and adults with lysosomal acid lipase deficiency…

Arrowhead discontinues multiple drug candidates for liver disease

December 1, 2016
Arrowhead Pharmaceuticals announced it has discontinued development of three drugs currently being investigated in clinical trials for the treatment of various forms of…
More Headlines »
CME

Cirrhosis and Hepatic Encephalopathy – Managing Their Consequences and Complications

This activity is supported by an educational grant from Salix Pharmaceuticals, a division of Valeant Pharmaceuticals North America LLC.

Cirrhosis, or advanced fibrosis of the liver, can lead to serious health sequelae or death. However, substantial…
More »
GI Bookshelf

Question 28: I Have A Patient With Biliary-Type Pain, But No Other Evidence Of Bile Duct Disease (Normal Diameter Duct On Ultrasound, Normal Liver Function Tests). How Should Such A Patient Be Managed?

From Curbside Consultation in Endoscopy: 49 Clinical Questions, Second Edition
More »
Video
Meeting News

VIDEO: Albireo CEO discusses cholestatic therapy pipeline

November 20, 2018
More »
Healio Jobs